{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:50:56Z","timestamp":1791582656322,"version":"4.3.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00210-026-05627-9","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T03:28:59Z","timestamp":1782358139000},"page":"19459-19469","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrated phenotypic\u2013genotypic characterization of antimicrobial resistance in uropathogens: implications for targeted therapy in a North Indian cohort"],"prefix":"10.1007","volume":"399","author":[{"given":"Tanveer Ahmad","family":"Mir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talib","family":"Shareef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Showkat Ahmad","family":"Lone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajad Ahmad","family":"Mir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junaid","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bashir Ahmad","family":"Ganai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"key":"5627_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11040516","volume":"11","author":"N Ahmed","year":"2022","unstructured":"Ahmed N, Khalid H, Mushtaq M, Basha S, Rabaan AA, Garout M, Halwani MA, Al Mutair A, Alhumaid S, Al Alawi Z, Yean CY (2022) The molecular characterization of virulence determinants and antibiotic resistance patterns in human bacterial uropathogens. Antibiotics (Basel) 11:516. https:\/\/doi.org\/10.3390\/antibiotics11040516","journal-title":"Antibiotics (Basel)"},{"key":"5627_CR2","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jgar.2018.03.009","volume":"14","author":"S Basu","year":"2018","unstructured":"Basu S, Mukherjee M (2018) Incidence and risk of co-transmission of plasmid-mediated quinolone resistance and extended-spectrum \u03b2-lactamase genes in fluoroquinolone-resistant uropathogenic Escherichia coli: a first study from Kolkata, India. J Glob Antimicrob Resist 14:217\u2013223. https:\/\/doi.org\/10.1016\/j.jgar.2018.03.009","journal-title":"J Glob Antimicrob Resist"},{"key":"5627_CR3","doi-asserted-by":"publisher","first-page":"211","DOI":"10.21315\/tlsr2024.35.2.10","volume":"35","author":"J-J Chin","year":"2024","unstructured":"Chin J-J, Lee H-M, Lee S-Y, Lee Y-Y, Chew C-H (2024) High carriage of tetA, sul1, sul2 and bla TEM resistance genes among the multidrug-resistant uropathogenic Escherichia coli (UPEC) strains from Malaysian patients. Trop Life Sci Res 35:211\u2013225. https:\/\/doi.org\/10.21315\/tlsr2024.35.2.10","journal-title":"Trop Life Sci Res"},{"key":"5627_CR4","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.jiac.2017.11.013","volume":"24","author":"H-S Choe","year":"2018","unstructured":"Choe H-S, Lee S-J, Cho Y-H, \u00c7ek M, Tando\u011fdu Z, Wagenlehner F, Bjerklund-Johansen TE, Naber K, Asian Investigators GPIU (2018) Aspects of urinary tract infections and antimicrobial resistance in hospitalized urology patients in Asia: 10-year results of the global prevalence study of infections in urology (GPIU). J Infect Chemother 24:278\u2013283. https:\/\/doi.org\/10.1016\/j.jiac.2017.11.013","journal-title":"J Infect Chemother"},{"key":"5627_CR5","unstructured":"CLSI (2024) Clinical & Laboratory Standards Institute: CLSI Guidelines [WWW Document]. Clinical & Laboratory Standards Institute. URL https:\/\/clsi.org\/. Accessed 1.2.25"},{"key":"5627_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s00284-025-04321-y","volume":"82","author":"BA Fomda","year":"2025","unstructured":"Fomda BA, Qadri U, Bashir G, Qadri SM, Nazir SS, Hakak I (2025) Superbug surge-a tale of seven-year battle against escalating antimicrobial resistance in North India. Curr Microbiol 82:340. https:\/\/doi.org\/10.1007\/s00284-025-04321-y","journal-title":"Curr Microbiol"},{"key":"5627_CR7","doi-asserted-by":"publisher","first-page":"3991","DOI":"10.2147\/IDR.S362445","volume":"15","author":"E Gantasala","year":"2022","unstructured":"Gantasala E, Bhat S, Saralaya V, Jayaram M, Udayalaxmi J (2022) Genotypic and phenotypic expression of antibiotic resistance patterns of uropathogenic enterobacteriaceae. Infect Drug Resist 15:3991\u20133999. https:\/\/doi.org\/10.2147\/IDR.S362445","journal-title":"Infect Drug Resist"},{"key":"5627_CR8","doi-asserted-by":"publisher","first-page":"DC09","DOI":"10.7860\/JCDR\/2014\/9349.4889","volume":"8","author":"S Gupta","year":"2014","unstructured":"Gupta S, Kapur S, Padmavathi D (2014) Comparative prevalence of antimicrobial resistance in community-acquired urinary tract infection cases from representative states of northern and southern India. J Clin Diagn Res 8:DC09-DC12. https:\/\/doi.org\/10.7860\/JCDR\/2014\/9349.4889","journal-title":"J Clin Diagn Res"},{"key":"5627_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.genrep.2021.101230","volume":"24","author":"S Gupta","year":"2021","unstructured":"Gupta S, Tripathi P, Shrivastava S (2021) Molecular studies and characterization of genes associated in drug resistance of uro-pathogens in central India. Gene Rep 24:101230. https:\/\/doi.org\/10.1016\/j.genrep.2021.101230","journal-title":"Gene Rep"},{"key":"5627_CR10","unstructured":"Handa VL, Patel BN, Bhattacharya A, Kothari RK, Kavathia G, Vyas BRM (2026) Prevalence and molecular characterization of \u03b2-lactamase and quinolone resistance genes in imipenem-non-susceptible uropathogenic Escherichia coli (UPEC) Isolates [WWW Document]. URL. Accessed 3.26.26"},{"key":"5627_CR11","doi-asserted-by":"publisher","first-page":"4702","DOI":"10.1038\/s41598-025-89240-5","volume":"15","author":"Y He","year":"2025","unstructured":"He Y, Zhao J, Wang L, Han C, Yan R, Zhu P, Qian T, Yu S, Zhu X, He W (2025) Epidemiological trends and predictions of urinary tract infections in the global burden of disease study 2021. Sci Rep 15:4702. https:\/\/doi.org\/10.1038\/s41598-025-89240-5","journal-title":"Sci Rep"},{"key":"5627_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11112937","volume":"11","author":"A Husna","year":"2023","unstructured":"Husna A, Rahman MM, Badruzzaman ATM, Sikder MH, Islam MR, Rahman MT, Alam J, Ashour HM (2023) Extended-spectrum \u03b2-lactamases (ESBL): challenges and opportunities. Biomedicines 11:2937. https:\/\/doi.org\/10.3390\/biomedicines11112937","journal-title":"Biomedicines"},{"key":"5627_CR13","doi-asserted-by":"publisher","first-page":"0","DOI":"10.1097\/MRM.0000000000000363","volume":"36","author":"N Hussein","year":"2023","unstructured":"Hussein N (2023) Molecular detection of blaTEM, blaCTX-M and blaSHV genes in ESbL harboring uropthogenic Escherichia coli (UPEC) isolated from UTIs in Baghdad\/Iraq. Rev Res Med Microbiol 36:0\u2013000. https:\/\/doi.org\/10.1097\/MRM.0000000000000363","journal-title":"Rev Res Med Microbiol"},{"key":"5627_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0232710","volume":"15","author":"N Kammili","year":"2020","unstructured":"Kammili N, Rani M, Styczynski A, Latha M, Pavuluri PR, Reddy V, Alsan M (2020) Plasmid-mediated antibiotic resistance among uropathogens in primigravid women-Hyderabad, India. PLoS One 15:e0232710. https:\/\/doi.org\/10.1371\/journal.pone.0232710","journal-title":"PLoS One"},{"key":"5627_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens14121254","volume":"14","author":"F Khalid","year":"2025","unstructured":"Khalid F, Aljohani WJ, Akram A, Bukhari A, Khojah OT (2025) Epidemiology and antimicrobial resistance of uropathogens in a tertiary care center in Riyadh, Saudi Arabia: a one-year retrospective analysis. Pathogens 14:1254. https:\/\/doi.org\/10.3390\/pathogens14121254","journal-title":"Pathogens"},{"key":"5627_CR16","doi-asserted-by":"publisher","DOI":"10.1155\/2024\/5014876","volume":"2024","author":"\u0130 Ko\u00e7er","year":"2024","unstructured":"Ko\u00e7er \u0130, Eri\u0307nmez M, Zer Y (2024) Genetic evaluation of heteroresistance among carbapenem-susceptible clinical isolates of enterobacterales. Can J Infect Dis Med Microbiol 2024:5014876. https:\/\/doi.org\/10.1155\/2024\/5014876","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"5627_CR17","doi-asserted-by":"publisher","first-page":"502","DOI":"10.3947\/ic.2024.0083","volume":"56","author":"T Mansoor","year":"2024","unstructured":"Mansoor T, Angmo D, Nehvi N (2024) Prevalence and antimicrobial susceptibility of wound pathogens in a tertiary care hospital in Kashmir: a cross-sectional study. Infect Chemother 56:502\u2013509. https:\/\/doi.org\/10.3947\/ic.2024.0083","journal-title":"Infect Chemother"},{"key":"5627_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-024-09023-7","volume":"24","author":"MIA Mohammedkheir","year":"2024","unstructured":"Mohammedkheir MIA, Gaafar EM, AbdAlla EGE (2024) Assessment of BlaTEM, BlaSHV, and BlaCTX-M genes of antibiotic resistance in Gram-negative bacilli causing urinary tract infections in Khartoum State: a cross-sectional study. BMC Infect Dis 24:141. https:\/\/doi.org\/10.1186\/s12879-024-09023-7","journal-title":"BMC Infect Dis"},{"key":"5627_CR19","doi-asserted-by":"publisher","DOI":"10.1099\/acmi.0.000321","volume":"4","author":"S Mohapatra","year":"2022","unstructured":"Mohapatra S, Panigrahy R, Tak V, J. V. S, K. C. S, Chaudhuri S, Pundir S, Kocher D, Gautam H, Sood S, Das BK, Kapil A, Hari P, Kumar A, Kumari R, Kalaivani M, R. A, Salve HR, Malhotra S, Kant S (2022) Prevalence and resistance pattern of uropathogens from community settings of different regions: an experience from India. Access Microbiol 4:000321. https:\/\/doi.org\/10.1099\/acmi.0.000321","journal-title":"Access Microbiol"},{"key":"5627_CR20","doi-asserted-by":"publisher","first-page":"001","DOI":"10.3855\/jidc.9486","volume":"12","author":"T Muderris","year":"2018","unstructured":"Muderris T, Durmaz R, Ozdem B, Dal T, \u00dcnaldi \u00d6, Aydo\u011fan S, Celikbilek N, Acikgoz Z (2018) Role of efflux pump and OprD porin expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolates. J Infect Dev Ctries 12:001\u2013008. https:\/\/doi.org\/10.3855\/jidc.9486","journal-title":"J Infect Dev Ctries"},{"key":"5627_CR21","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1007\/s00345-019-03071-4","volume":"38","author":"R \u00d6zt\u00fcrk","year":"2020","unstructured":"\u00d6zt\u00fcrk R, Murt A (2020) Epidemiology of urological infections: a global burden. World J Urol 38:2669\u20132679. https:\/\/doi.org\/10.1007\/s00345-019-03071-4","journal-title":"World J Urol"},{"key":"5627_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/4251486","volume":"2022","author":"M Rahman","year":"2022","unstructured":"Rahman M, Hossain M, Rubaya R, Halder J, Karim M, Bhuiya AA, Khatun A, Alam J (2022) Association of antibiotic resistance traits in uropathogenic Escherichia coli (UPEC) isolates. Can J Infect Dis Med Microbiol 2022:1. https:\/\/doi.org\/10.1155\/2022\/4251486","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"5627_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-023-08803-x","volume":"23","author":"BT Regassa","year":"2023","unstructured":"Regassa BT, Tosisa W, Eshetu D, Beyene D, Abdeta A, Negeri AA, Teklu DS, Tasew G, Tulu B, Awoke T (2023) Antimicrobial resistance profiles of bacterial isolates from clinical specimens referred to Ethiopian Public Health Institute: analysis of 5-year data. BMC Infect Dis 23:798. https:\/\/doi.org\/10.1186\/s12879-023-08803-x","journal-title":"BMC Infect Dis"},{"key":"5627_CR24","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1186\/s12879-024-09489-5","volume":"24","author":"L Robino","year":"2024","unstructured":"Robino L, Sauto R, Morales C, Navarro N, Gonz\u00e1lez MJ, Cruz E, Neffa F, Zeballos J, Scavone P (2024) Presence of intracellular bacterial communities in uroepithelial cells, a potential reservoir in symptomatic and non-symptomatic people. BMC Infect Dis 24:590. https:\/\/doi.org\/10.1186\/s12879-024-09489-5","journal-title":"BMC Infect Dis"},{"key":"5627_CR25","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.3346\/jkms.2014.29.8.1178","volume":"29","author":"M-R Seo","year":"2014","unstructured":"Seo M-R, Kim S-J, Kim Y, Kim J, Choi TY, Kang JO, Wie S-H, Ki M, Cho YK, Lim S-K, Lee JS, Kwon KT, Lee H, Cheong HJ, Park DW, Ryu SY, Chung M-H, Pai H (2014) Susceptibility of Escherichia coli from community-acquired urinary tract infection to fosfomycin, nitrofurantoin, and temocillin in Korea. J Korean Med Sci 29:1178\u20131181. https:\/\/doi.org\/10.3346\/jkms.2014.29.8.1178","journal-title":"J Korean Med Sci"},{"key":"5627_CR26","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41579-024-01092-4","volume":"23","author":"MR Timm","year":"2025","unstructured":"Timm MR, Russell SK, Hultgren SJ (2025) Urinary tract infections: pathogenesis, host susceptibility and emerging therapeutics. Nat Rev Microbiol 23:72\u201386. https:\/\/doi.org\/10.1038\/s41579-024-01092-4","journal-title":"Nat Rev Microbiol"},{"key":"5627_CR27","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1128\/AAC.48.4.1295-1299.2004","volume":"48","author":"M Wang","year":"2004","unstructured":"Wang M, Sahm DF, Jacoby GA, Hooper DC (2004) Emerging plasmid-mediated quinolone resistance associated with the qnr gene in Klebsiella pneumoniae clinical isolates in the United States. Antimicrob Agents Chemother 48:1295\u20131299. https:\/\/doi.org\/10.1128\/AAC.48.4.1295-1299.2004","journal-title":"Antimicrob Agents Chemother"},{"key":"5627_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms11092169","volume":"11","author":"P Whelan","year":"2023","unstructured":"Whelan P, Lucey B, Finn K (2023) Uropathogenic Escherichia coli (UPEC)-associated urinary tract infections: the molecular basis for challenges to effective treatment. Microorganisms 11:2169. https:\/\/doi.org\/10.3390\/microorganisms11092169","journal-title":"Microorganisms"},{"key":"5627_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.888205","author":"X Yang","year":"2022","unstructured":"Yang X, Chen H, Zheng Y, Qu S, Wang H, Yi F (2022) Disease burden and long-term trends of urinary tract infections: a worldwide report. Front Public Health. https:\/\/doi.org\/10.3389\/fpubh.2022.888205","journal-title":"Front Public Health"},{"key":"5627_CR30","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s00345-021-03913-0","volume":"40","author":"Z Zeng","year":"2022","unstructured":"Zeng Z, Zhan J, Zhang K, Chen H, Cheng S (2022) Global, regional, and national burden of urinary tract infections from 1990 to 2019: an analysis of the global burden of disease study 2019. World J Urol 40:755\u2013763. https:\/\/doi.org\/10.1007\/s00345-021-03913-0","journal-title":"World J Urol"},{"key":"5627_CR31","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.bsheal.2023.01.001","volume":"5","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Zhang N, Wang M, Luo M, Peng Y, Li Z, Xu J, Ou M, Kan B, Li X, Lu X (2023) The prevalence and distribution of aminoglycoside resistance genes. Biosaf Health 5:14\u201320. https:\/\/doi.org\/10.1016\/j.bsheal.2023.01.001","journal-title":"Biosaf Health"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05627-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05627-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05627-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:02:59Z","timestamp":1791579779000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05627-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["5627"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05627-9","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,25]]},"assertion":[{"value":"3 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"An ethical approval was obtained from the Institutional Review Board of GMC, Baramulla, J&K, India, with Approval No: GMC\/BLA\/IRB\/2024\/Cert\/09 (Dated; 23\/04\/2024).","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"A written consent was obtained from all patients involved in the study.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}